Drugs / Phenofibrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05909800 | Sep 2022 → Jul 2024 | type 1 diabetes mellitus | Medical University of Warsaw | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phenofibrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05909800 ↗ |
| Route | Oral | “Administred orally, once daily, for 12 months.” NCT05909800 ↗ |